CMS Pushes Sunshine Act Data Collection Deadline to 2013
The Centers for Medicare and Medicaid Services announced earlier this month that it was pushing back the deadline by which pharmaceutical companies must begin collecting data on the amount of money th... [Read More]
 
Keeping REMS Up to Standards
Experts from the Accreditation Council for CME, the Food and Drug Administration, and the commercial support community address how to ensure REMS activities align with the ACCME’s Standards for Commer... [Read More]
 
#CMEReg Twitter Chat 2/14/12: The Sunshine Act & CME
Chris Lamond and Andy Rosenberg from the CME Coalition joined a discussion on a special #CMEReg chat on 2/14/12 to talk about a proposed amendment to the Sunshine Act that has been causing anxiety in ... [Read More]
 
CME Coalition Urges CME Providers to Take Action Against Sunshine Act Proposed Rule
The CME Coalition is asking CME providers to oppose a proposed rule to the Physician Payment Sunshine Act that could make CME providers responsible for payment reporting to commercial supporters. [Read More]
 
FDA Releases REMS Blueprint
The Food and Drug Administration last week announced in the Federal Register that it has released its draft "Blueprint for Prescriber Continuing Education Program." [Read More]
 
CME Coalition Releases Voluntary Code of Conduct
The CME Coalition, which launched last June to provide a voice on Capitol Hill for those who believe continuing medical education can and does improve patient care, has released a voluntary Code of C... [Read More]
 
The Risks and Rewards of Pharmaceutical Meetings
Pharma and life sciences meetings are essential for business, but meeting managers must be careful about compliance if they want to mitigate regulatory risks. This wrap-up from our annual forum will s... [Read More]
 
Massachusetts House Votes to Repeal Pharma Marketing Law
The Massachusetts House of Representatives has voted 128-22 to repeal the Massachusetts Pharmaceutical and Medical Device Manufacturer Code of Conduct. [Read More]